FOXP3 and ovarian carcinoma: Despite several early reports associating this subset of T regulatory cells with a poor outcome [22,23], a meta-analysis of 869 patients over several studies did not conclude that FoxP3 Tregs in the tumors of ovarian-cancer patients are a significant prognostic indicator of survival [24].